Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01675063 · ClinicalTrials.gov registry record · NA
Minimally Invasive Cardiac Output Monitoring Device
A NA study of Cardiac Event, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 77
- Enrollment target
- 1
- Study location
NCT01675063: Completed NA study of Cardiac Event, sponsored by University of Michigan.
NCT01675063 is a NA study of Cardiac Event that has completed, run by University of Michigan. The registered enrollment target is 77 participants, below the 1,063-participant average among 3 other Cardiac Event trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01675063, a NA study of Cardiac Event, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 77 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall goal of this collaborative study is to advance the novel "pulse contour analysis" to the point at which it can be incorporated into a real-time device. The specific objective is to establish an auto-calibration algorithm that conveniently yields cardiac output (CO) in units of liters-per-minute. To achieve this objective, the waveforms for analysis and reference pulmonary artery catheter CO measurements will be recorded from critically ill patients and then analyzed off-line at Retia Medical. Successful completion of this study may ultimately help lead to improved outcomes of critically ill patients.
Primary Outcome
The primary outcome of this work is to establish a dataset that would enable the calculation of a predicted cardiac output using waveform analysis from multiple sensors. The primary outcome of this work is the number of subjects that successfully contributed data.
Conditions Studied
Interventions
- DEVICE Retia Non-Invasive Sensors
Study Locations (1)
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2012-08 |
| Est. Completion | 2015-10 |
| Phase | NA |
What the finished NCT01675063 record still lists
NCT01675063 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 77 participants, a relatively small participant target, below the 1,063-participant average among 3 other Cardiac Event trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Cardiac Event appearing as the primary indexed condition, and to 1 intervention - of which Retia Non-Invasive Sensors is the first listed.
NCT01675063 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT01675063 about?
NCT01675063 is a clinical study titled "Minimally Invasive Cardiac Output Monitoring Device". The overall goal of this collaborative study is to advance the novel "pulse contour analysis" to the point at which it can be incorporated into a real-time device. The specific objective is to establish an auto-calibration algorithm that conveniently yields cardiac output (CO) in units of liters-per...
What is the current status of trial NCT01675063?
This trial is currently completed. It is a NA study. The enrollment target is 77 participants. The study started on 2012-08. Estimated completion is 2015-10.
What conditions does trial NCT01675063 study?
This clinical trial studies the following conditions: Cardiac Event.
What interventions are being tested in trial NCT01675063?
The interventions under investigation include: Retia Non-Invasive Sensors (DEVICE).
Who is sponsoring clinical trial NCT01675063?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01675063 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiac Event
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02127398 · 77 participants · Phase 2
Stool Transplants to Treat Refractory Clostridium Difficile Colitis
- NCT04159103 · 77 participants · Phase 1
Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia
- NCT04683003 · 77 participants · Phase 3
A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura
- NCT05004116 · 77 participants · Phase 1
A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia